Read
Listen
Watch
Play
Find
Mail

  • Quotes

  • NAVs

  • News

  • Messages

  • Opinions

  • Notices

  • Videos
Moneycontrol.com India | Balance Sheet > Pharmaceuticals > Balance Sheet of Jagsonpal Pharmaceuticals - BSE: 507789, NSE: JAGSNPHARM
  You are here  :   Moneycontrol    Market    Balance Sheet - Jagsonpal Pharmaceuticals
COMPANY SEARCH
Company Name, Moneycontrol, ISIN,
BSE or NSE code
Information
  Price & Chart
  Co. History
  Co. Background
  Board Of Directors
  Capital Structure
  Listing Info
  Locations
  Bulk Deals
Financials
   Balance Sheet
  Profit & Loss
  Quarterly Results
  Half Yearly Results
  Nine Monthly Results
  Yearly Results
Annual Report
  Directors Report
  Chairman's Speech
  Auditors Report
  Notes To Accounts
  Accounting Policy
  Cash Flow
  Raw Materials
  Finished Products
Announcements
  Board Meetings
  AGM/EGM
  Dividends
  Bonus
  Rights
  Splits
  News
Compare with Peers
  Price
  Market Cap
  Net Sales
  Net Profit
  Total Assets
Related
  Holding in MF's
  Research Reports
Ads by Google
Jagsonpal Pharmaceuticals
BSE: 507789 NSE: JAGSNPHARM ISIN: INE048B01027
Industry : Pharmaceuticals
Balance Sheet ------------------- in Rs. Cr. -------------------
Dec '02 Mar '04 Mar '05 Mar '06 Mar '07
15 mths 15 mths 12 mths 12 mths 12 mths
Sources Of Funds
Total Share Capital 3.27 3.27 13.10 13.10 13.10
Equity Share Capital 3.27 3.27 13.10 13.10 13.10
Share Application Money 0.00 0.00 0.00 0.00 0.00
Preference Share Capital 0.00 0.00 0.00 0.00 0.00
Reserves 42.51 47.24 39.78 42.11 44.60
Revaluation Reserves 15.79 15.50 15.26 15.03 14.80
Networth 61.57 66.01 68.14 70.24 72.50
Secured Loans 28.71 27.95 29.94 34.93 43.53
Unsecured Loans 7.44 5.06 6.61 7.15 5.87
Total Debt 36.15 33.01 36.55 42.08 49.40
Total Liabilities 97.72 99.02 104.69 112.32 121.90
Dec '02 Mar '04 Mar '05 Mar '06 Mar '07
15 mths 15 mths 12 mths 12 mths 12 mths
Application Of Funds
Gross Block 34.57 38.60 40.94 43.14 43.71
Less: Accum. Depreciation 6.11 7.84 9.39 11.14 13.02
Net Block 28.46 30.76 31.55 32.00 30.69
Capital Work in Progress 0.00 0.00 0.00 4.69 13.03
Investments 0.00 0.00 0.00 0.00 0.00
Inventories 47.60 56.68 67.32 54.46 44.21
Sundry Debtors 27.99 22.78 20.38 36.52 45.59
Cash and Bank Balance 3.34 3.16 1.23 2.52 2.49
Total Current Assets 78.93 82.62 88.93 93.50 92.29
Loans and Advances 5.29 8.83 13.19 9.99 10.40
Fixed Deposits 0.00 0.84 1.22 1.37 1.06
Total CA, Loans & Advances 84.22 92.29 103.34 104.86 103.75
Deffered Credit 0.00 0.00 0.00 0.00 0.00
Current Liabilities 10.45 13.53 16.90 20.92 15.65
Provisions 4.50 10.50 13.29 8.32 9.94
Total CL & Provisions 14.95 24.03 30.19 29.24 25.59
Net Current Assets 69.27 68.26 73.15 75.62 78.16
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00
Total Assets 97.73 99.02 104.70 112.31 121.88
Contingent Liabilities 0.00 0.00 0.00 0.00 0.00
Book Value (Rs) 139.81 154.25 20.18 21.07 22.03
BSE:  507789 NSE:  JAGSNPHARM Reuters:  JGSN.BO   JGSN.NS
Source : Asian CERC

Feedback

CNBC TV18 CNN IBN CNBC Awaaz IBN 7 IBN LOKMAT

Chat

Ramesh Damani

Member BSE ,

(09 Sep- 16:00hrs)

What's good investment now?  

Upcoming Chat Schedule »

Previous Chat Transcripts »

Poll

Will the Nifty hold 4300 in this spell of weakness?

Yes No
 
View Result  View all comments

Newsletter

Keep in touch with News day & night. Subscribe to:

Mobile Services

Want us to track your stocks 24x7?

Subscribe to our Stock Messaging System

Get news on the move SMS to 52622

  • SMS M for Market News
  • SMS B for Latest Business News
  • SMS S (stock name) for latest news